|
|
The Guiding Value of Bedside Transcranial Doppler Ultrasound in Bridging Treatment of Acute Cerebral Infarction |
JIANG Shunfu, XU Jie, CAO Minghua, WU Mingchao, ZOU Yongzhou, XU Dehong, XU Hong, BI Jiancan, WU Yilang |
Jingdezhen No.1 People's Hospital, Jiangxi Province, Jingdezhen 333000, China |
|
|
Abstract Objective: To explore the guiding value of bedside transcranial Doppler (TCD) ultrasound in the bridging treatment of acute cerebral infarction. Method: A total of 80 patients with acute cerebral infarction who were admitted to the Department of Neurology of the Jingdezhen No.1 People's Hospital from May 2019 to January 2022 were selected, and they were randomly divided into two groups according to random number table, with 40 cases in each group. Both groups were treated with bridging treatment. The control group was treated with reference to the Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke in China during the treatment process, the observation group was additionally treated with bedside TCD to guide bridging treatment. The national institutes of health stroke scale (NIHSS) scores, modified Rankin scale (mRS) scores, and Gonner evaluated the success rate of revascularization, complication rate and mortality were compared between the two groups. Result: NIHSS score at 72 h after treatment and mRS score at 60 d after treatment in observation group were lower than those in control group (P<0.05). The vascular recirculation rate was 80.00% in the observation group after 72 h of treatment, which was higher than 57.50% in the control group (P<0.05). The complication rate in observation group was 5.00%, which was lower than 20.00% in control group (P<0.05). The fatality rate in the observation group was 10.00% after 6 months, which was lower than 27.50% in the control group (P<0.05). Conclusion: Bridging treatment can achieve good therapeutic effect in patients with acute cerebral infarction, and the bedside TCD guidance can reduce the patient's nerve defect, promote the patient's functional recovery, and help improve the success rate of revascularization during the treatment process, reduce complication rate and mortality.
|
Received: 20 September 2022
|
|
|
|
|
|
|